참고문헌
- The average life expectancy (0 years life expectancy) and healthy life. Available from http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=2758. Accessed March 25, 2016.
- Mortality trends by cause of death. Available from http://www.index.go.kr/potal/main/EachDtlPageDetail.do?idx_cd=1012. Accessed March 25, 2016.
- Overview of Korean healthcare system based on the Korea Healthcare Panel (2008-2012). Available from https://www.khp.re.kr:444/ver_2/04_study/study01.jsp. Accessed March 25, 2016.
- Vital Statistics in 2014 on Cause of Death. Available from http://kostat.go.kr/portal/korea/kor_nw/2/6/2/index.board?bmode=read&aSeq=348539. Accessed April 14, 2016.
- Reden J. Molsidomine. Blood Vessels 1990;27(2-5):282-94.
- Markham A, Plosker GL, Goa KL. Nicorandil: An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects. Drugs 2000;60(4):955-74. https://doi.org/10.2165/00003495-200060040-00007
- Horinaka S. Use of nicorandil in cardiovascular disease and its optimization. Drugs 2011;71(9):1105-19. https://doi.org/10.2165/11592300-000000000-00000
- Cross HR. Trimetazidine for stable angina pectoris. Expert Opin on Pharmacother 2001;2(5):857-75. https://doi.org/10.1517/14656566.2.5.857
- Chrusciel P, Rysz J, Banach M. Defining the role of trimetazidine in the treatment of cardiovascular disorders: Some insights on its role in heart failure and peripheral artery disease. Drugs 2014;74(9):971-80. https://doi.org/10.1007/s40265-014-0233-5
- Roland E. Safety profile of an anti-anginal agent with potassium channel opening activity: An overview. Eur Heart J 1993;14(suppl. B):48-52.
- Sasaki J, Saeki Y, Kawasaki K, et al. A multicenter comparison of nicorandil and diltiazem on serum lipid, apolipoprotein, and lipoprotein levels in patients with ischemic heart disease. Cardiovac Drugs Ther 1992;6(5):471-4. https://doi.org/10.1007/BF00055603
- Wagner G. Selected issues from an overview on nicorandil: Tolerance, duration of action, and long-term efficacy. J Cardiovasc Pharmacol 1992;20(suppl. 3):S86-92. https://doi.org/10.1097/00005344-199206203-00015
- Krumenacker M, Roland E. Clinical profile of nicorandil: An overview of its hemodynamic properties and therapeutic efficacy. J Cardiovasc Pharmacol 1992;20(suppl. 3):S93-102.
- Dunn N, Freemantle S, Pearce G, et al. Safety profile of nicorandil - Prescription-event monitoring (PEM) study. Pharmacoepidemiol Drug Saf 1999;8(3):197-205. https://doi.org/10.1002/(SICI)1099-1557(199905/06)8:3<197::AID-PDS422>3.0.CO;2-T
- Terai H, Yamanishi H, Shimahara M. Nicorandil-induced tongue ulceration with or without fungal infection. Odontology 2012;100(1):100-3. https://doi.org/10.1007/s10266-011-0015-4
- Scully C, Azul AM, Crighton A, et al. Nicorandil can induce severe oral ulceration. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;91(2):189-93. https://doi.org/10.1067/moe.2001.110306
- Egred M. Nicorandil-associated ulcerations. Eur J Gastroenterol Hepatol 2007;19(5):395-8. https://doi.org/10.1097/MEG.0b013e328010b184
- Salim F, Joshi A, Hopkins C. Ulceration of the nasal dorsum: a rare cause? J Laryngol Otology 2014;128(3):289-91. https://doi.org/10.1017/S0022215113003629
- Gayet JL, Paganelli F, Cohen-Solal A. Update on the medical treatment of stable angina. Arch Cardiovas Dis 2011;104(10):536-44. https://doi.org/10.1016/j.acvd.2011.08.001
- Fraunfelder FW, Fraunfelder FT. Conjunctival and corneal ulceration associated with nicorandil. Cutan Ocul Toxicol 2014;33(2):120-1. https://doi.org/10.3109/15569527.2013.811248
- Trechot F, Batta B, Petitpain N, et al. A case of nicorandil-induced unilateral corneal ulceration. Int Wound J 2014;11(3):238-9. https://doi.org/10.1111/iwj.12081
- Campolmi N, Guy C, Cinotti E, et al. Corneal perforation: Another side effect of nicorandil. Cutan Ocul Toxicol 2014;33(2):96-8. https://doi.org/10.3109/15569527.2013.812105
- Trechot P, Petitpain N, Guy C, et al. Nicorandil: From ulcer to fistula into adjacent organs. Int Wound J 2013;10(2):210-3. https://doi.org/10.1111/j.1742-481X.2012.00966.x
- Shapey IM, Agbamu D, Newall N, et al. Nicorandil-associated ulceration of the gastrointestinal tract: side effects requiring surgical intervention. Int J of Colorectal Dis 2015;30(8):1143-5. https://doi.org/10.1007/s00384-014-2112-7
- McClellan KJ, Plosker GL. Trimetazidine: A review of its use in stable angina pectoris and other coronary conditions. Drugs 1999;58(1):143-57. https://doi.org/10.2165/00003495-199958010-00016
- Marti Masso JF, Marti I, Carrera N, et al. Trimetazidine induces parkinsonism, gait disorders and tremor. Therapie 2005;60(4):419-22. https://doi.org/10.2515/therapie:2005061
- Marti Masso JF. Trimetazidine-induced parkinsonism. Neurologia 2004;19(7):392-5.
- Masmoudi K, Masson H, Gras V, et al. Extrapyramidal adverse drug reactions associated with trimetazidine: A series of 21 cases. Fundam Clin Pharmacol 2012;26(2):198-203. https://doi.org/10.1111/j.1472-8206.2011.01008.x
- Messin R, Dubois C, Famaey JP. Comparative effects of once-daily molsidomine in coronary patients from two distinct European ethnicities. Adv Ther 2008;25(11):1200-14. https://doi.org/10.1007/s12325-008-0117-8
- Messin R, Carreer-Bruhwyler F, Dubois C, et al. Efficacy and safety of once- and twice-daily formulations of molsidomine in patients with stable angina pectoris: Double-blind and open-label studies. Adv Ther 2006;23(1):107-30. https://doi.org/10.1007/BF02850352
- Beaufils P, Kolsky H, Haiat R, et al. The influence of molsidomine on infarct size: An acute post-infarction pilot study with 303 patients. Cardiovasc Drugs Ther 1988;2(1):127-32. https://doi.org/10.1007/BF00054263
- Balakumaran K, Hugenholtz PG, Tijssen JGP, et al. Molsidomine, an effective long-acting anti-anginal drug. Eur Heart J 1983;4(9):655-61. https://doi.org/10.1093/oxfordjournals.eurheartj.a061538
- Nishimura M, Tokoro T, Nishida M, et al. Oral Nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: A randomized trial. Am J Kidney Dis 2009;54(2):307-17. https://doi.org/10.1053/j.ajkd.2009.03.025
- Blanc P, Aouifi A, Bouvier H, et al. Safety of oral nicorandil before coronary artery bypass graft surgery. Br J Anaesth 2001;87(6):848-54. https://doi.org/10.1093/bja/87.6.848
- Wolf DL, Hearron AE, Metzler CM, et al. The pharmacokinetics and haemodynamic effects of continuous nicorandil infusion in healthy volunteers. Eur J Clin Pharmacol 1993;45(5):437-43. https://doi.org/10.1007/BF00315515
- Ulvenstam G, Diderholm E, Frithz G, et al. Antianginal and antiischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study. J Cardiovasc Pharmacol 1992;20(suppl. 3):S67-73. https://doi.org/10.1097/00005344-199206203-00012
- Doring G. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: Results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients. J Cardiovasc Pharmacol 1992;20(suppl. 3):S74-81.
- Raftery EB, Lahiri A, Hughes LO, et al. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina. Eur Heart J 1993;14(suppl. B):35-9. https://doi.org/10.1093/eurheartj/14.suppl_B.35
- Di Napoli P, Taccardi AA, Barsotti A. Long term cardioprotective action of trimetazidine and potential effect on the inflammatory process in patients with ischaemic dilated cardiomyopathy. Heart 2005;91(2):161-5. https://doi.org/10.1136/hrt.2003.031310
- Shlyakhto EV, Almazov VVA, Nifontov EM, et al. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris. Am J Cardiovasc Drugs 2002;2(2):119-24. https://doi.org/10.2165/00129784-200202020-00005
- Dalla-Volta S, Maraglino G, Della-Valentina P, et al. Comparison of trimetazidine with nifedipine in effort angina: A double-blind, crossover study. Cardiovasc Drugs Ther 1990;4(suppl. 4):853-9. https://doi.org/10.1007/BF00051292
- Ruzyllo W, Szwed H, Sadowski Z, et al. Efficacy of trimetazidine in patients with recurrent angina: A subgroup analysis of the TRIMPOL II study. Curr Med Res Opin 2004;20(9):1447-54. https://doi.org/10.1185/030079904X2637
- Bertel O, Noll G. Additional molsidomine in refractory unstable angina pectoris. Cardiovasc Drugs Ther 1988;2(1):107-11. https://doi.org/10.1007/BF00054260
- Makolkin VI, Osadchiy KK. Trimetazidine modified release in the treatment of stable angina: TRIUMPH Study. Clin Drug Investig 2004;24(12):731-8. https://doi.org/10.2165/00044011-200424120-00004
- Palaniappan M, Selvarajan S, George M, et al. Pattern of adverse drug reactions reported with cardiovascular drugs in a tertiary care teaching hospital. J Clin Diagn Res 2015;9(11):FC01-4.
- Toquero L, Briggs CD, Bassuini MM, et al. Anal ulceration associated with nicorandil: Case series and review of the literature. Colorectal Disease 2006;8(8):717-20. https://doi.org/10.1111/j.1463-1318.2006.00972.x
- Kapoor S. Nicorandil and its associated gastrointestinal side effects. Pacing Clin Electrophysiol 2013;36(5):662. https://doi.org/10.1111/pace.12105
- Baker RP, Al-Kubati W, Atuf M, et al. Nicorandil-induced severe perianal ulceration. Tech Coloproctol 2007;11(4):343-5. https://doi.org/10.1007/s10151-007-0378-2
- Yap T, Philippou P, Perry M, et al. Nicorandil-induced penile ulcerations: A case series. BJU Int 2011;107(2):268-71. https://doi.org/10.1111/j.1464-410X.2010.09463.x
- McDaid J, Reichl C, Hamzah I, et al. Diverticular fistulation is associated with nicorandil usage. Ann R Coll Surg Engl 2010;92(6):463-5. https://doi.org/10.1308/rcsann.2010.92.6.463
- Kinoshita M, Sakai K. Pharmacology and therapeutic effects of nicorandil. Cardiovasc Drugs Ther 1990;4(4):1075-88. https://doi.org/10.1007/BF01856503
- Balakumar P, Kavitha M, Nanditha S. Cardiovascular drugs-induced oral toxicities: A murky area to be revisited and illuminated. Pharmacol Res 2015;102:81-9. https://doi.org/10.1016/j.phrs.2015.09.007
- Onay-Besikci A, Özkan SA. Trimetazidine revisited: A comprehensive review of the pharmacological effects and analytical techniques for the determination of trimetazidine. Cardiovas Ther 2008;26(2):147-65. https://doi.org/10.1111/j.1527-3466.2008.00043.x
- The Korean-English Medical Terminology, 5th Edition, Korean Medical Association. Available from http://term.kma.org/. Accessed April 14, 2016.
- Lehmann G, Reiniger G, Beyerle A, et al. Clinical comparison of antiischemic efficacy of isosorbide dinitrate and molsidomine. J Cardiovasc Pharmacol 1998;31(1):25-30. https://doi.org/10.1097/00005344-199801000-00004
- Lehmann G, Reiniger G, Beyerle A, et al. Haemodynamic evaluation of two regimens of molsidomine in patients with chronic congestive heart failure. Eur J Clin Pharmacol 1995;48(2):109-14. https://doi.org/10.1007/BF00192734
- Falase BA, Bajaj BS, Wall TJ, et al. Nicorandil-induced peripheral vasodilatation during cardiopulmonary bypass. Ann Thorac Surg 1999;67(4):1158-9. https://doi.org/10.1016/S0003-4975(99)00132-0
- Bricaud H, Brottier L, Barat JL, et al. Cardioprotective effect of trimetazidine in severe ischemic cardiomyopathy. Cardiovasc Drugs Ther 1990;4 Suppl 4:861-5. https://doi.org/10.1007/BF00051293
- Brottier L, Barat JL, Combe C, et al. Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy. Eur Heart J 1990;11(3):207-12. https://doi.org/10.1093/oxfordjournals.eurheartj.a059685